Home > Insider Trading > Filing (0000899243-19-023733)

Filing Details

Accession Number:: 0000899243-19-023733
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-17 16:05:20
Reporting Period:: 2019-09-17

Accepted Time:: 2019-09-17 16:05:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1692830	Satsuma Pharmaceuticals Inc.	STSA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1619841	M. Rajeev Shah	C/O Ra Capital Management, Llc 200 Berkeley Street 18Th Floor Boston MA 02116		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2019-09-17	1,642,879	$0.00	1,642,879	No	4	C	Indirect	See FN
Common Stock, $0.0001 Par Value	Acquisiton	2019-09-17	1,139,635	$0.00	2,782,514	No	4	C	Indirect	See FN
Common Stock, $0.0001 Par Value	Acquisiton	2019-09-17	365,530	$0.00	3,148,044	No	4	C	Indirect	See FN
Common Stock, $0.0001 Par Value	Acquisiton	2019-09-17	200,481	$0.00	3,348,525	No	4	C	Indirect	See FN
Common Stock, $0.0001 Par Value	Acquisiton	2019-09-17	1,140,946	$15.00	4,489,471	No	4	P	Indirect	See FN
Common Stock, $0.0001 Par Value	Acquisiton	2019-09-17	192,387	$15.00	4,681,858	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	P	Indirect	See FN
No	4	P	Indirect	See FN

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-09-17	1,642,879	$0.00	1,642,879	$0.00
Common Stock	Series A Preferred Stock	Disposition	2019-09-17	365,530	$0.00	365,530	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-09-17	1,139,635	$0.00	1,139,635	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-09-17	200,481	$0.00	200,481	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Reflects a 1-for-4.7 reverse stock split effective upon the effectiveness of the registration statement for the Issuer's initial public offering.
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's Common Stock, for no additional consideration, on a 1:1 basis at the consummation of Issuer's initial public offering.
RA Capital Management, LLC (the "Advisor") is the general partner of RA Capital Healthcare Fund, L.P.("RA Capital Fund") and the investment advisor of an account owned by a separately managed account (the "Account"). Peter Kolchinsky is the sole manager of the Advisor, and Mr. Shah is a member of the Advisor. Mr. Shah has no pecuniary interest in the reported securities held by the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by RA Capital Fund except to the extent of his pecuniary interest therein.
Represents shares held by RA Capital Fund.
RA Capital Fund purchased an additional 1,140,946 shares of issuer's common stock in connection with the initial public offering at the offering price of $15.00 per share.
Represents shares held by the Account.
The Account purchased an additional 192,387 shares of issuer's common stock in connection with the initial public offering at the offering price of $15.00 per share.
Includes (a) 3,923,460 shares of Common Stock that are held by RA Capital Fund and (b) 758,398 shares of Common Stock that are held in the Account.